Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome

Editorial: Novel Immunological Biomarkers for Allogeneic HSCT Outcome

Bibliographic Details
Main Authors:	Raffaella Greco, Jacopo Peccatori, Francesca Bonifazi, John A. Snowden, Fabio Ciceri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-03-01
Series:	Frontiers in Immunology
Subjects:	biomarkers allogeneic transplantation outcomes graft-versus-host disease transplant-related mortality cytokines
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.670822/full

Similar Items

Interleukin-6 as Biomarker for Acute GvHD and Survival After Allogeneic Transplant With Post-transplant Cyclophosphamide
by: Raffaella Greco, et al.
Published: (2019-10-01)

Risk Factors for Rehospitalizations after Allogeneic Hematopoietic Stem Cell Transplantation
by: MYu Drokov, et al.
Published: (2019-12-01)

Biomarkers for Allogeneic HCT Outcomes
by: Djamilatou Adom, et al.
Published: (2020-04-01)

SEVERE (GRADE III-IV) ACUTE GRAFT VERSUS HOST DISEASE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
by: Irena Preložnik-Zupan, et al.
Published: (2002-09-01)

Effect of Early Post-Transplantation Tacrolimus Concentration on the Risk of Acute Graft-Versus-Host Disease in Allogenic Stem Cell Transplantation
by: Nidhi Sharma, et al.
Published: (2021-02-01)

Elevated Galectin-3 Plasma Concentrations in Recipients of Allogeneic Hematopoietic Cell Transplantation
by: Zachariah DeFilipp, et al.
Published: (2019-08-01)

Comparative Study of Mycophenolate Mofetil and Methotrexate in Graft-Versus-Host Disease Prophylaxis in Adult Recipients of Related and Unrelated Allo-HSCT
by: IS Moiseev, et al.
Published: (2018-12-01)

Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation
by: T A Bykova, et al.
Published: (2013-08-01)

Dermoscopy of Cutaneous Graft-Versus-Host-Disease in Patients After Allogeneic Hematopoietic Stem Cell Transplantation
by: Grażyna Kaminska-Winciorek, et al.
Published: (2020-07-01)

CD4+ T cells in aged or thymectomized recipients of allogeneic stem cell transplantations
by: Hiroshi Takahashi, et al.
Published: (2015-01-01)

Interleukin-22 in graft-versus-host disease after allogeneic stem cell transplantation
by: BAPTISTE eLAMARTHEE, et al.
Published: (2016-04-01)

Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation
by: Hideaki Fujiwara
Published: (2021-08-01)

Correlation of mixed lymphocyte culture with chronic graft-versus-host disease following allogeneic stem cell transplantation
by: J.E.L. Visentainer, et al.
Published: (2002-05-01)

Mouse Models of Antigen Presentation in Hematopoietic Stem Cell Transplantation
by: Motoko Koyama, et al.
Published: (2021-09-01)

The Outcome of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis: a Retrospective Study in a Single Center
by: Mei-Fang Hou, et al.
Published: (2015-03-01)

Twice-daily intravenous bolus tacrolimus infusion: A safe and effective regimen for graft-versus-host disease prophylaxis
by: Hamza Hashmi, et al.
Published: (2020-12-01)

Interleukin-6 in Allogeneic Stem Cell Transplantation: Its Possible Importance for Immunoregulation and As a Therapeutic Target
by: Tor Henrik Anderson Tvedt, et al.
Published: (2017-06-01)

A Case of Multiple Sclerosis—Like Relapsing Remitting Encephalomyelitis Following Allogeneic Hematopoietic Stem Cell Transplantation and a Review of the Published Literature
by: Joyutpal Das, et al.
Published: (2020-05-01)

Allogeneic Stem Cell Transplantation with CD34+ Cell Selection
by: Elisa Roldan, et al.
Published: (2019-09-01)

De novo glomerulitis associated with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: A single-center experience
by: Yul Hee Cho, et al.
Published: (2013-09-01)

Advances in Intestinal Barrier Preservation and Restoration in the Allogeneic Hematopoietic Cell Transplantation Setting
by: Martyna Tyszka, et al.
Published: (2021-06-01)

Metabolic Reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has Begun
by: Reena Kumari, et al.
Published: (2020-11-01)

Regulatory B cells promote graft-versus-host disease prevention and maintain graft-versus-leukemia activity following allogeneic bone marrow transplantation
by: Yue Hu, et al.
Published: (2017-03-01)

The Role of Immune Checkpoint Molecules for Relapse After Allogeneic Hematopoietic Cell Transplantation
by: Natalie Köhler, et al.
Published: (2021-03-01)

Ocular Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation: A Review of Current Knowledge and Recommendations
by: Nariman Nassiri, et al.
Published: (2013-01-01)

“Is this the GVHD?” A qualitative exploration of quality of life issues in individuals with graft-versus-host disease following allogeneic stem cell transplant and their experiences of a specialist multidisciplinary bone marrow transplant service
by: Isabella de Vere Hunt, et al.
Published: (2021-01-01)

Late Post-Operative Occurrence of Dentin Hypersensitivity in Adult Patients Following Allogeneic Hematopoietic Stem Cell Transplantation—A Preliminary Report
by: Agnieszka Bogusławska-Kapała, et al.
Published: (2021-08-01)

Treatment of acute host-versus-graft reaction in patients after allogeneic hematopoietic cell transplantation with multipotent mesenchymal stromal cells from a bone marrow donor
by: N A Petinati, et al.
Published: (2012-07-01)

Strategies for Enhancing and Preserving Anti-leukemia Effects Without Aggravating Graft-Versus-Host Disease
by: Ying-Jun Chang, et al.
Published: (2018-12-01)

A real life use of ruxolitinib in patients with acute and chronic graft versus host disease refractory to corticosteroid treatment in Latin American patients
by: Mauricio Sarmiento, et al.
Published: (2021-07-01)

Long-term survival without graft-versus-host-disease following infusion of allogeneic myeloma-specific Vβ T cell families
by: S. Yado, et al.
Published: (2019-11-01)

Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease via the Treg/Th17 Balance in Allo-HSCT Recipients
by: Lijie Han, et al.
Published: (2018-04-01)

Invariant Natural Killer T Cells As Suppressors of Graft-versus-Host Disease in Allogeneic Hematopoietic Stem Cell Transplantation
by: Melissa Mavers, et al.
Published: (2017-07-01)

Encapsulating peritoneal sclerosis in a patient after allogeneic hematopoietic stem cell transplantation: a case report
by: Yoshimitsu Shimomura, et al.
Published: (2019-01-01)

Post-Transplant Cyclophosphamide and Tacrolimus—Mycophenolate Mofetil Combination Governs GVHD and Immunosuppression Need, Reducing Late Toxicities in Allogeneic Peripheral Blood Hematopoietic Cell Transplantation from HLA-Matched Donors
by: Fabrizio Carnevale-Schianca, et al.
Published: (2021-03-01)

CLINICAL SIGNIFICANCE OF BCL–2 GENE EXPRESSION FOR THE PROGNOSIS AND MONITORING OF ACUTE GRAFT–VERSUS–HOST–DISEASE (AGVHD) IN ALLO–HSCT
by: M. I. Zaraiski
Published: (2014-07-01)

Allogeneic hematopoietic stem cell transplantation in patients with multiple myeloma
by: Maiia V. Firsova, et al.
Published: (2021-07-01)

The Activating NKG2C Receptor Is Significantly Reduced in NK Cells after Allogeneic Stem Cell Transplantation in Patients with Severe Graft-versus-Host Disease
by: Lambros Kordelas, et al.
Published: (2016-10-01)

Efficacy and safety of prophylactic modified donor lymphocyte infusion following allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia
by: YANG Luxin, et al.
Published: (2019-12-01)

Diagnosis of acute graft-versus-host disease in the gastrointestinal tract of patients undergoing allogeneic hematopoietic stem cell transplantation. A descriptive and critical study of diagnostic tests
by: Leticia Rocha Borges, et al.
Published: (2020-07-01)